Xtant sells Coflex/CoFix and OUS businesses to Companion Spine for $19.2M

Xtant Medical Holdings, Inc.

Total consideration $19.2M: $11M cash at close plus $8.2M promissory note due Dec. 31, 2025.
Non-refundable $2.5M deposit paid; up to two additional $2.5M deposits if financing delays occur.
Net proceeds will reduce debt by $9.6M (prepayment to MidCap) and improve liquidity.
Closing expected Q3 2025, subject to Companion obtaining financing and other conditions.
Divestiture sharpens focus on core orthobiologics; certain employees will transition to buyer.

item 1.01item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.